Cell based diagnostics co PixCell raises $2m

The financing follows completion of CE mark registration of the HemoScreen Complete Blood Count (CBC) analyzer.

PixCell Medical Technologies Ltd., which is developing a patented Cell Based Diagnostics technology for the Point of Care (POC), has raised $2 million following completion of CE mark registration of the HemoScreen Complete Blood Count (CBC) analyzer. The financing was raised from its existing strategic investor.

The Yokne'am based company said that the funds will be used to establish PixCells European presence and expand its ongoing clinical efforts to introduce the HemoScreen technology to the market. The HemoScreen CBC analyzer brings the laboratory to physicians' offices, to patients homes, isolated communities, ambulances and even to field units. Requiring only a minute blood sample and zero maintenance, it is also ideal for the hematology assessment of newborn babies.

PixCell's Viscoelastic Focusing and automated sample preparation proprietary technology is a breakthrough in live cell diagnostics, utilizing lab accurate and robust testers that are small, simple to operate and inexpensive.

PixCell Medical CEO Dr. Avishay Bransky said, PixCells goal is to make lab restricted tests more accessible, easy to use and affordable. With this new investment, PixCell is poised to expand its clinical efforts and further demonstrate how the HemoScreen technology can support diagnostics and treatment selection at the point of care.

PixCells HemoScreen is a miniature, portable Point of Care Complete Blood Count (CBC) tester that employs disposable self-contained cartridges. The HemoScreen provides 20 standard CBC parameters including: RBC indices, WBC count, Hemoglobin, WBC 5-diff and platelets parameters. Tests results are obtained within 5 minutes using only 20l of capillary/venous blood.

PixCell Medical plans to start a multi-center pilot study in Europe and Israel to evaluate the safety and performance of the HemoScreen system. Prior pre-clinical studies have successfully demonstrated its precision and accuracy in CBC analysis.

Published by Globes [online], Israel business news - www.globes-online.com - on October 7, 2013

Copyright of Globes Publisher Itonut (1983) Ltd. 2013

Twitter Facebook Linkedin RSS Newsletters Israel Business Conference 2018